Search Results - "Wilms, Erik B."

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management by van Breemen, Melanie SM, MD, Wilms, Erik B, Pharm D, Vecht, Charles J, Dr

“…Summary Epilepsy is common in patients with brain tumours and can substantially affect daily life, even if the tumour is under control. Several factors affect…”
Get full text

Vancomycin pharmacokinetic model development in patients on intermittent online hemodiafiltration by Westra, Niels, Proost, Johannes H, Franssen, Casper F M, Wilms, Erik B, van Buren, Marjolijn, Touw, Daan J

“…Vancomycin is frequently used in hemodialysis (HD) and in hemodiafiltration (HDF) patients and is usually administered in the last 30 or 60 minutes of a…”
Get full text

Interactions between antiepileptic and chemotherapeutic drugs by Vecht, Charles J, Wagner, G Louis, Wilms, Erik B

“…Cancer and epilepsy commonly co-occur, and concomitant administration of antiepileptic (AEDS) and chemotherapeutic drugs (CTDs) is necessary in many cases…”
Get more information

Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate by Sobels, Annemieke, Lentjes, Koen J, Froeling, Frank M J A, van Nieuwkoop, Cees, Wilms, Erik B

“…The optimal drug of choice, its time of administration and duration of antibiotic prophylaxis in patient undergoing a TURP procedure are still matters of…”
Get full text

Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study by Leegwater, Emiel, Dol, Lisa, Benard, Menno R., Roelofsen, Eveline E., Delfos, Nathalie M., van der Feltz, Machteld, Mollema, Femke P. N., Bosma, Liesbeth B. E., Visser, Loes E., Ottens, Thomas H., van Burgel, Nathalie D., Arbous, Sesmu M., El Bouazzaoui, Lahssan H., Knevel, Rachel, Groenwold, Rolf H. H., de Boer, Mark G. J., Visser, Leo G., Rosendaal, Frits R., Wilms, Erik B., van Nieuwkoop, Cees

“…Introduction Remdesivir is a registered treatment for hospitalised patients with COVID-19 that has moderate clinical effectiveness. Anecdotally, some patients’…”
Get full text

Ceftriaxone for the Treatment of Chronic Bacterial Prostatitis: A Case Series and Literature Review by Kuiper, Sander G, Ploeger, Maarten, Wilms, Erik B, van Dijk, Marleen M, Leegwater, Emiel, Huis In't Veld, Robert A G, van Nieuwkoop, Cees

“…Chronic bacterial prostatitis is increasingly difficult to treat due to rising antimicrobial resistance limiting oral treatment options. In this case series,…”
Get full text

Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein Inhibitors by Leegwater, Emiel, Strik, Anne, Wilms, Erik B, Bosma, Liesbeth B E, Burger, David M, Ottens, Thomas H, van Nieuwkoop, Cees

“…Abstract We report a case of a man with COVID-19 who developed acute hepatotoxicity related to remdesivir with probable interaction of P-glycoprotein (P-gp)…”
Get full text

Examination of Particulate Contamination in Parenteral Injections and Infusions Following Fluid Withdrawal Utilizing Conventional Needles and Filter Needles: Assessment of Compliance and Comparative Analysis by van den Berg, Roland B, Ganesh, Monica, Crul, Mirjam, Wilms, Erik B, Swart, Eleonora L, Westerman, Elsbeth M

“…Particulate contamination, the unintentional presence of particles in parenteral fluids, is associated with potential risks such as phlebitis and…”
Get more information

Drug-drug interaction: decreased posaconazole trough concentrations during concomitant flucloxacillin treatment by Wortman, Julia M, Leegwater, Emiel, Van Lammeren-Venema, Daniëlle, Van Nieuwkoop, Cees, Sobels, Annemieke, Wilms, Erik B

“…Posaconazole is used as prophylaxis of invasive fungal disease in immune-compromised haematological patients with prolonged neutropenia after intensive…”
Get full text

Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in people with cystic fibrosis and healthy controls by van der Meer, Renske, Wilms, Erik B, Sturm, Richart, Heijerman, Harry G.M.

“…•Current dosing recommendations when combining ivacaftor with CYP3A4 inhibitors can be maintained.•Exposure to ivacaftor was higher in healthy volunteers than…”
Get full text

Hypokalaemia in patients treated with intravenous flucloxacillin: Incidence and risk factors by Leegwater, Emiel, Westgeest, Annette C., Schippers, Emile F., Wilms, Erik B., Nieuwkoop, Cees, Visser, Loes E.

“…Introduction Hypokalaemia is a potentially life‐threatening adverse event of flucloxacillin with unknown incidence. The risk of flucloxacillin‐induced…”
Get full text

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection by Kuiper, Sander G, Dijkmans, Anneke C, Wilms, Erik B, Kamerling, Ingrid M C, Burggraaf, Jacobus, Stevens, Jasper, van Nieuwkoop, Cees

“…Abstract Objectives To evaluate the pharmacokinetics and clinical effectiveness of IV and oral fosfomycin treatment in patients with recurrent urinary tract…”
Get full text

Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy by Leegwater, Emiel, Baidjoe, Lauren, Wilms, Erik B, Visser, Leo G, Touw, Daniel J, de Winter, Brenda C M, de Boer, Mark G J, van Paassen, Judith, van den Berg, Charlotte H S B, van Prehn, Joffrey, van Gelder, Teun, Moes, Dirk Jan A R

“…The goal of the study was to describe the population pharmacokinetics of trimethoprim, sulfamethoxazole, and N-acetyl sulfamethoxazole in hospitalized…”
Get full text

Intoxications with synthetic cannabinoids by Zanen, Jolanda G, Leegwater, Emiel, Schippers, Emile F, Wilms, Erik B

“…Synthetic Cannabinoid Receptor Agonists (SCRAs) are a group of New Psychoactive Substances. They are used recreationally to mimic the effects of THC in…”
Get more information

Evaluation of the drug-drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort by Jansen, Anouk M E, Eggermont, Margot N, Wilms, Erik B, Aziz, Sami, Reijers, Monique, Roukema, Jolt, Warris, Adilia, Brüggemann, Roger J M, van der Meer, Renske

“…Limited data on the clinical management of drug-drug interactions between triazoles and Cystic Fibrosis transmembrane conductance regulator (CFTR) modulators…”
Get full text

Sulpiride intoxication: Case report of a rare intoxication by Zonneveld, Svenja, Gawi, Adina, Wilms, Erik B., Vliet, Peter, Westerman, Elsbeth M

“…Intoxications with sulpiride, an antipsychotic, are rare, and only limited literature is available. We describe a successful treatment of a sulpiride…”
Get full text

Elexacaftor/tezacaftor/ivacaftor in liver or kidney transplanted people with cystic fibrosis using tacrolimus, a drug-drug interaction study by van der Meer, Renske, Wilms, Erik B, Eggermont, Margot N, Paalvast, Helena M, van Luin, Matthijs, van Rossen, Richard C J M, Heijerman, Harry G M

“…•The drug-drug interaction between tacrolimus and elexacaftor/tezacaftor/ivacaftor resulted in an increased exposure of tacrolimus in all subjects.•No adverse…”
Get full text

Colistin: Revival of an Old Polymyxin Antibiotic by Dijkmans, Anneke C, Wilms, Erik B, Kamerling, Ingrid M C, Birkhoff, Willem, Ortiz-Zacarías, Natalia V, van Nieuwkoop, Cees, Verbrugh, Henri A, Touw, Daan J

“…Colistin (polymyxin E) is a positively charged deca-peptide antibiotic that disrupts the integrity of the outer membrane of the cell wall of gram-negative…”
Get full text

Body weight is negatively associated with direct oral anticoagulant trough concentrations in dabigatran and apixaban users by Borst, Jacqueline M., Rein, Nienke, Bakker, Emilie C. M. D., Vukadin, Nikola, Rier, Mike, Mairuhu, Albert T. A., Hudig, Francisca, Bosma, Liesbeth B. E., Wilms, Erik B., Visser, Loes E.

Get full text

The influence of exocrine pancreatic function on the exposure and pharmacokinetics of ivacaftor in people with cystic fibrosis by van der Meer, Renske, Wilms, Erik B, Eggermont, Margot N, Paalvast, Helena M, van Rossen, Richard C J M, Heijerman, Harry G M

“…•The exocrine pancreatic function of people with cystic fibrosis (pwCF) does not significantly influence the absorption and exposure of ivacaftor.•The use of…”
Get full text